Markets:

Overview

News

Currencies

International

Treasuries

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

4.194 +0.034 (+0.82%)

Delayed Quote Updated: 2:46 PM EDT, Oct 14, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Jaguar Health, Inc. - Common Stock

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

24 25 Next >

Jaguar Health Announces Publication in Breast Cancer Research and Treatment of Investigator-Initiated Phase 2 HALT-D Study of Crofelemer for Prevention of Chemotherapy-Induced Diarrhea (CID) in Breast Cancer Patients

October 26, 2022

Via ACCESSWIRE

Why Minerva Neurosciences Shares Dipped By Around 70%; Here Are 90 Biggest Movers From Yesterday ↗

October 18, 2022

Gainers Acorda Therapeutics, Inc. (NASDAQ: ACOR) surged 163.8% to close at $0.8970 on Monday after the company announced a $16.5 million award and royalty/supply relief in the AMPYRA arbitration case.

Via Benzinga

Jaguar Health Reports Voting Results from 2022 Special Meeting of Stockholders

September 30, 2022

Via ACCESSWIRE

Jaguar Health Provides Company Updates and Reports 2022 Second Quarter Financials

August 22, 2022

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

Jaguar Health to Host Investor Webcast Monday, August 22nd at 8:30 AM Eastern Time Regarding Q2 2022 Financials & Corporate Updates

August 17, 2022

Via ACCESSWIRE

Jaguar Health Announces Issuance of U.S. Patent 11,389,424, a Methods and Compositions Patent for Treating Chemotherapy-Induced Diarrhea

August 09, 2022

Via ACCESSWIRE

Why Bank of America Shares Are Trading Higher? Here Are 66 Stocks Moving In Monday's Mid-Day Session ↗

October 17, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares rose 78.9% to $0.93 after jumping 48% on Friday.

Via Benzinga

Why Jaguar Health Stock Is Popping Off ↗

October 17, 2022

Jaguar Health Inc (NASDAQ: JAGX) shares are trading higher by 12.9% to $0.16 during Monday's session after the company was granted orphan drug designation by the European Medicines agency for...

Via Benzinga

European Medicines Agency Grants Orphan Drug Designation for Crofelemer for Microvillus Inclusion Disease (MVID), a Second Rare Disease Indication

October 17, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 17, 2022

Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

October 17, 2022

Good morning, investor! It's time to start off the trading week with a breakdown of the biggest pre-market stock movers on Monday!

Via InvestorPlace

Why Acorda Therapeutics Shares Are Trading Higher By 55%; Here Are 28 Stocks Moving Premarket ↗

October 17, 2022

Gainers

Via Benzinga

Jaguar Animal Health Co-Sponsoring Closing Ceremony at Veterinary Cancer Society Annual Conference on October 15th to Drive Awareness of Jaguar's Take C.H.A.R.G.E. (Canine Health And ReGistry Exchange) Initiative

October 12, 2022

Via ACCESSWIRE

Jaguar Health Subsidiary Napo Pharmaceuticals Announces Activation by FDA of Investigational New Drug (IND) Application for NP-300, a Novel Drug Candidate for the Symptomatic Relief and Treatment of Diarrhea from Cholera and Other Pathogens

September 29, 2022

Via ACCESSWIRE

Jaguar Health to Present at Lytham Partners Fall 2022 Investor Conference on September 28th and at Ladenburg Thalmann 2022 Healthcare Conference on September 29th

September 22, 2022

Via ACCESSWIRE

Why NeuroBo Pharmaceuticals Is Trading Higher By Around 55%; Here Are 25 Stocks Moving Premarket ↗

September 15, 2022

Gainers NeuroBo Pharmaceuticals, Inc. (NASDAQ: NRBO) rose 54.6% to $26.07 in pre-market trading after the company entered into an exclusive license agreement with Dong-A.

Via Benzinga

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 30, 2022

Via Benzinga

Jaguar Health Seeks FDA Nod For Cholera Candidate Study ↗

August 30, 2022

Jaguar Health (NASDAQ: JAGX) has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration for its subsidiary Napo's NP-300 drug product candidate for the...

Via Benzinga

Jaguar Health Announces Submission of Investigational New Drug (IND) Application to FDA for Drug Candidate for the Symptomatic Relief of Diarrhea from Cholera

August 30, 2022

Via ACCESSWIRE

Jaguar Health Secures Additional Capital Through Sale of Royalty Rights Related to Future Crofelemer and Lechlemer Revenue Stream

August 25, 2022

Via ACCESSWIRE

Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary ↗

August 23, 2022

Via Benzinga

Looking Into Jaguar Health's Return On Capital Employed ↗

August 23, 2022

According to Benzinga Pro data, during Q2, Jaguar Health (NASDAQ:JAGX) posted sales of $2.92 million. Earnings were up 48.3%, but Jaguar Health still reported an overall loss of $9.39 million.

Via Benzinga

Jaguar Health Announces that Orphan Drug Designation Application Submitted to the FDA for Crofelemer for a Severe Congenital Diarrheal Disorder (CDD) Has Been Accepted for Review

August 23, 2022

Via ACCESSWIRE

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 22, 2022

Gainers ABVC BioPharma (NASDAQ:ABVC) shares increased by 12.8% to $0.97 during Monday's after-market session. The company's market cap stands at $31.6 million.

Via Benzinga

Earnings Scheduled For August 22, 2022 ↗

August 22, 2022

Companies Reporting Before The Bell • Jaguar Health (NASDAQ:JAGX) is estimated to report quarterly loss at $0.22 per share on revenue of $3.10 million.

Via Benzinga

Jaguar Health's Earnings: A Preview ↗

August 19, 2022

Jaguar Health (NASDAQ:JAGX) is set to give its latest quarterly earnings report on Monday, 2022-08-22. Here's what investors need to know before the announcement. Analysts estimate that Jaguar Health...

Via Benzinga

Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq's Bid Price Rule

August 19, 2022

Via ACCESSWIRE

Gallup Survey Estimates Nearly 30 Million U.S. Dog Owners Have Experienced Canine Cancer, with Many Saying it Negatively Impacted Their Own Quality of Life

August 10, 2022

Via ACCESSWIRE

Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 05, 2022

Via ACCESSWIRE

< Previous 1 2

...

14 15 16 17 18 19 20 21 22

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

HOW TRANSPARENT IS NH? FOLLOW OUR SCORECARD

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

All News about Jaguar Health, Inc. - Common Stock

The Newspapers of New England Family

We continue to need local support from our readers

HOW TRANSPARENT IS NH? FOLLOW OUR SCORECARD

Jaguar Health, Inc. - Common Stock (NQ:JAGX)

All News about Jaguar Health, Inc. - Common Stock

Enjoying the Concord Monitor?

Sign in